B-cell lymphoma 6 and the molecular pathogenesis of diffuse large B-cell lymphoma

Current Opinion in Hematology

Volumn 15, Issue 4, 2008, Pages 381-390

  Ci, Weimin ^a   Polo, Jose M ^b   Melnick, Ari ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

B cell lymphoma 6; Non Hodgkin lymphoma; Transcription therapy; Transcriptional repression

Indexed keywords

ANTINEOPLASTIC AGENT; APTAMER; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BCL 6; STAT PROTEIN;

B LYMPHOCYTE; CANCER CHEMOTHERAPY; CANCER GROWTH; CELL DEATH; CELL FUNCTION; CELL MATURATION; DOWN REGULATION; DRUG MECHANISM; GENE EXPRESSION; GENE IDENTIFICATION; GENOMIC INSTABILITY; GERMINAL CENTER; HUMAN; LARGE CELL LYMPHOMA; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; PHYSIOLOGY;

GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; PROTO-ONCOGENE PROTEINS C-BCL-6; TRANSCRIPTION, GENETIC;

EID: 47149096182     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0b013e328302c7df     Document Type: Review

References (51)

1. Allman D, Jain A, Dent A, et al. BCL-6 expression during B-cell activation. Blood 1996; 87:5257-5268.
2. Dent AL, Shaffer AL, Yu X, et al. Control of inflammation, cytokine expression, and germinal center formation by BCL-6. Science 1997; 276:589-592.
3. Ye BH, Cattoretti G, Shen Q, et al. The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation. Nat Genet 1997; 16:161-170.
4. Ye BH. BCL-6 in the pathogenesis of non-Hodgkin's lymphoma. Cancer Invest 2000; 18:356-365.
5. Baron BW, Anastasi J, Montag A, et al. The human BCL6 transgene promotes the development of lymphomas in the mouse. Proc Natl Acad Sci USA 2004; 101:14198-14203.
6. Cattoretti G, Pasqualucci L, Ballon G, et al. Deregulated BCL6 expression recapitulates the pathogenesis of human diffuse large B cell lymphomas in mice. Cancer Cell 2005; 7:445-455.
7. Polo JM, Dell'Oso T, Ranuncolo SM, et al. Specific peptide interference reveals BCL6 transcriptional and oncogenic mechanisms in B-cell lymphoma cells. Nat Med 2004; 10:1329-1335.
8. Phan RT, Dalla-Favera R. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells. Nature 2004; 432:635-639.
9. Liu M, Duke JL, Richter DJ, et al. Two levels of protection for the Bcell genome during somatic hypermutation. Nature 2008; 451:841-845.
10. Pasqualucci L, Neumeister P, Goossens T, et al. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature 2001; 412:341-346.
11. Pasqualucci L, BhagatG, Jankovic M, et al. AID is required for germinal center- derived lymphomagenesis. Nat Genet 2008; 40:108-112.
12. Ranuncolo SM, Polo JM, Dierov J, et al. Bcl-6 mediates the germinal center B cell phenotype and lymphomagenesis through transcriptional repression of the DNA-damage sensor ATR. Nat Immunol 2007; 8:705-714.
13. Ranuncolo SM, Polo JM, MelnickA. BCL6 represses CHEK1 and suppresses DNA damage pathways in normal and malignant B-cells. Blood Cells Mol Dis 2008 [Epub ahead of print].
14. Phan RT, Saito M, Basso K, et al. BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells. Nat Immunol 2005; 6:1054-1060.
15. Cerchietti L, Polo J, DaSilva G, et al. Sequential transcription factor targeting for diffuse large B-cell lymphomas. Cancer Res 2008; 68:3361-3369.
16. Schwickert TA, Lindquist RL, Shakhar G, et al. In vivo imaging of germinal centres reveals a dynamic open structure. Nature 2007; 446:83-87.
17. Allen CD, Okada T, Tang HL, Cyster JG. Imaging of germinal center selection events during affinity maturation. Science 2007; 315:528-531.
18. Ci W, Polo JM, Dell'Oso T, Melnick A. A 'survival of the fittest' mechanism for weeding out potentially lymphomagenic B-cells during germinal center B-cell differentiation. Blood 2007; 110:171a-172a.
19. Phan RT, Saito M, Kitagawa Y, et al. Genotoxic stress regulates expression of the proto-oncogene Bcl6 in germinal center B cells. Nat Immunol 2007; 8:1132-1139.
20. KuoTC, Shaffer AL, Haddad J Jr, et al. Repression of BCL-6 is required for the formation of human memory B cells in vitro. J Exp Med 2007; 204:819-830.
21. Tunyaplin C, Shaffer AL, Angelin-Duclos CD, et al. Direct repression of prdm1 by Bcl-6 inhibits plasmacytic differentiation. J Immunol 2004; 173:1158-1165.
22. Basso K, Klein U, Niu H, et al. Tracking CD40 signaling during germinal center development. Blood 2004; 104:4088-4096.
23. Saito M, Gao J, Basso K, et al. A signaling pathway mediating downregulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma. Cancer Cell 2007; 12:280-292.
24. Teng Y, Takahashi Y, Yamada M, et al. IRF4 negatively regulates proliferation of germinal center B cell-derived Burkitt's lymphoma cell lines and induces differentiation toward plasma cells. Eur J Cell Biol 2007; 86:581-589.
25. Li Z, Wang X, Yu RY, et al. BCL-6 negatively regulates expression of the NF-kappaB1 p105/p50 subunit. J Immunol 2005; 174:205-214.
26. Perez-Rosado A, Artiga M, Vargiu P, et al. BCL6 represses NFkappaB activity in diffuse large B-cell lymphomas. J Pathol 2008; 214:498-507.
27. Polo JM, Juszczynski P, Monti S, et al. Transcriptional signature with differ- ential expression of BCL6 target genes accurately identifies BCL6-dependent diffuse large B cell lymphomas. Proc Natl Acad Sci USA 2007; 104:3207-3212.
28. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000; 403:503-511.
29. Lam LT, Davis RE, Pierce J, et al. Small molecule inhibitors of IkappaB kinase are selectively toxic for subgroups of diffuse large B-cell lymphoma defined by gene expression profiling. Clin Cancer Res 2005; 11:28-40.
30. Lam LT, Wright G, Davis RE, et al. Cooperative signaling through the STAT3 and NF-{kappa}B pathways in subtypes of diffuse large B cell lymphoma. Blood 2008; 111:3701-3713.
31. Ding BB, Yu JJ, Yu RY, et al. Constitutively activated STAT3 promotes cell proliferation and survival in the activated B-cell subtype of diffuse large B-cell lymphomas. Blood 2008; 111:1515-1523.
32. Reljic R, Wagner SD, Peakman LJ, Fearon DT. Suppression of signal transducer and activator of transcription 3-dependent B lymphocyte terminal differentiation by BCL-6. J Exp Med 2000; 192:1841-1848.
33. Walker SR, Nelson EA, Frank DA. STAT5 represses BCL6 expression by binding to a regulatory region frequently mutated in lymphomas. Oncogene 2007; 26:224-233.
34. Lee SC, Bottaro A, Chen L, Insel RA. Mad1 is a transcriptional repressor of Bcl-6. Mol Immunol 2006; 43:1965-1971.
35. Huynh KD, Fischle W, Verdin E, Bardwell VJ. BCoR, a novel corepressor involved in BCL-6 repression. Genes Dev 2000; 14:1810-1823.
36. Ahmad KF, Melnick A, Lax S, et al. Mechanism of SMRT corepressor recruitment by the BCL6 BTB domain. Mol Cell 2003; 12:1551-1564.
37. Karagianni P, Wong J. HDAC3: taking the SMRT-N-CoRrect road to repression. Oncogene 2007; 26:5439-5449.
38. Ghetu AF, Corcoran CM, Cerchietti L, et al. Structure of a BCOR corepressor peptide in complex with the BCL6 BTB domain dimer. Mol Cell 2008; 29:384-391.
39. Gearhart MD, Corcoran CM, Wamstad JA, Bardwell VJ. Polycomb group and SCF ubiquitin ligases are found in a novel BCOR complex that is recruited to BCL6 targets. Mol Cell Biol 2006; 26:6880-6889.
40. Sanchez C, Sanchez I, Demmers JA, et al. Proteomics analysis of Ring1B/ Rnf2 interactors identifies a novel complex with the Fbxl10/Jhdm1B histone demethylase and the Bcl6 interacting corepressor. Mol Cell Proteomics 2007; 6:820-834.
41. Parekh S, Polo JM, Shaknovich R, et al. BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanisms. Blood 2007; 110:2067-2074.
42. FujitaN, Jaye DL, Geigerman C, et al. MTA3and Mi-2/NuRD complex regulate cell fate during B-lymphocyte differentiation. Cell 2004; 119:75-86.
43. Jaye DL, Iqbal J, Fujita N, et al. The BCL6-associated transcriptional co-repressor, MTA3, is selectively expressed by germinal centre B cells and lymphomas of putative germinal centre derivation. J Pathol 2007; 213:106-115.
44. Chevallier N, Corcoran CM, Lennon C, et al. ETO protein of t(8;21) AML is a corepressor for Bcl-6 B-cell lymphoma oncoprotein. Blood 2004; 103: 1454-1463.
45. Mendez LM, Polo JM, Yu JJ, et al. CtBP is an essential corepressor for BCL6 autoregulation. Mol Cell Biol 2008; 28:2175-2186.
46. Toney LM, Cattoretti G, Graf JA, et al. BCL-6 regulates chemokine gene transcription in macrophages. Nat Immunol 2000; 1:214-220.
47. Chattopadhyay A, Tate SA, Beswick RW, et al. A peptide aptamer to antagonize BCL-6 function. Oncogene 2006; 25:2223-2233.
48. Da Silva G, Ghetu AF, Cerchietti L, et al. Design and development of small molecules for specific targeted therapy of diffuse large B-cell lymphoma. Blood 2007; 110:245-246a.
49. Parekh S, Prive GG, MelnickA. Therapeutic targeting of the BCL6 oncogene for diffuse large B-cell lymphomas. Leuk Lymphoma 2008; iFirst:1-9.
50. Iqbal J, Greiner TC, Patel K, et al. Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma. Leukemia 2007; 21:2332-2343.
51. Monti S, Savage KJ, Kutok JL, et al. Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. Blood 2005; 105:1851-1861.